CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $334,000 | +108.8% | 6,464 | 0.0% | 0.00% | +100.0% |
Q2 2022 | $160,000 | -1.2% | 6,464 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $162,000 | -31.1% | 6,464 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $235,000 | +111.7% | 6,464 | 0.0% | 0.00% | – |
Q3 2021 | $111,000 | +27.6% | 6,464 | 0.0% | 0.00% | – |
Q2 2021 | $87,000 | -73.7% | 6,464 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $331,000 | -17.2% | 6,464 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $400,000 | +13.0% | 6,464 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $354,000 | -4.8% | 6,464 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $372,000 | +43.1% | 6,464 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $260,000 | – | 6,464 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,796,516 | $45,142,000 | 7.90% |
GREAT POINT PARTNERS LLC | 1,000,000 | $5,790,000 | 4.09% |
Belmont Global Advisors, Inc. | 175,000 | $1,013,000 | 0.82% |
Broadfin Capital, LLC | 1,033,668 | $5,985,000 | 0.79% |
WASATCH ADVISORS LP | 2,650,551 | $15,347,000 | 0.15% |
BALYASNY ASSET MANAGEMENT L.P. | 1,158,613 | $6,708,000 | 0.09% |
Artal Group S.A. | 275,000 | $1,592,000 | 0.06% |
STONERIDGE INVESTMENT PARTNERS LLC | 41,355 | $239,000 | 0.05% |
A.R.T. Advisors, LLC | 33,501 | $193,000 | 0.01% |
BANQUE PICTET & CIE SA | 50,932 | $295,000 | 0.01% |